Literature DB >> 28275419

Early Diagnosis and Treatment of Coronary Heart Disease in Symptomatic Subjects With Advanced Vascular Atherosclerosis of the Carotid Artery (Type III and IV b Findings Using Ultrasound).

Ansgar Adams1, Waldemar Bojara2, Klaus Schunk3.   

Abstract

BACKGROUND: A study was conducted as to whether the early diagnosis of coronary heart disease (CHD) in symptomatic patients with advanced atherosclerosis of the carotid artery was more successful using ultrasound technology than exercise electrocardiography (ECG).
METHODS: Within the scope of an occupational screening program using subjects from diverse employment sectors, people were given the opportunity to determine their risk of heart attack. During the study, the total plaque area (TPA), the maximum plaque thickness in the carotid artery and the PROCAM scores of 3,513 healthy men and 2,088 healthy women between the ages of 20 and 65 were determined. During the subsequent follow-up study, 36 subjects developed symptoms such as exertional dyspnea, atypical angina pectoris (AP) or typical AP. Four patients displayed no symptoms. The initial cardiac diagnostic testing was conducted on 31 patients using an exercise ECG, four patients were assessed using a coronary angiogram, and five further patients were assessed using a computed tomography (CT) coronary angiogram. An ultrasound examination of the carotid artery of 39 patients revealed a type IV b finding and in one patient, the examination revealed a type III finding.
RESULTS: In 17 patients, the PROCAM score was < 10%, 13 patients had a score of 10-20% and 10 patients had a score of > 20%. In the final analysis, only two patients had entirely smooth coronary arteries, seven had coronary sclerosis, seven had a 30% stenosis, one had a 30-40% stenosis, one had a 40% stenosis, and 22 patients had a stenosis ≥ 50%, and in extreme cases, a left main coronary artery stenosis with three-vessel disease was shown. The exercise ECG only achieved a true positive result in four patients, and in 21 patients, the result was false negative.
CONCLUSIONS: Symptomatic patients with advanced atherosclerosis of the carotid artery (type III and type IV b findings) had a high risk for CHD. The diagnosis of CHD is better achieved by using carotid duplex than with an exercise ECG. Early treatment of the disease improves the patient's prognosis.

Entities:  

Keywords:  Cardiovascular risk; Carotid duplex; Coronary heart disease; PROCAM score; Total plaque area

Year:  2017        PMID: 28275419      PMCID: PMC5340519          DOI: 10.14740/cr516w

Source DB:  PubMed          Journal:  Cardiol Res        ISSN: 1923-2829


Introduction

Within the scope of an occupational screening program in the Koblenz area, people working in diverse sectors of the economy such as chemicals, glass, pharmaceuticals, administration, steel production, social services, paper production, printing, ceramics, IT, university, universities of applied science and retail were given the opportunity to determine their risk of heart attack. During the study, the total plaque area (TPA), the maximum plaque thickness in the carotid artery and the PROCAM scores of 5,601 healthy subjects (who had had no previous history of a cardiovascular event) between the ages of 20 and 65 (3,513 men and 2,088 women) were determined. In the mean follow-up study of period of 35.2 ± 21 months, seven strokes and 20 heart attacks have occurred to date. Seven bypass operations and four stent implantations have been performed, and stenoses (70% and 90%, respectively) have been revealed in two patients who underwent a coronary angiogram. Four subjects exhibited a type III finding and 26 subjects showed a type IV b finding in the ultrasound examination of the baseline study. The testing method involving the measurement of plaque burden and maximum plaque thickness was validated by means of a blinded examination of 500 patients in hospital 1 day prior to a scheduled coronary angiogram. This allowed the classification of the ultrasound findings into four types [1]. Patients with a type III or a type IV b finding in the ultrasound examination revealed one-, two- or three-vessel disease in 83% of cases. Eighty-seven percent of the patients suffering from a stenosing coronary heart condition were accurately predicted (type III or type IV b finding during the carotid duplex). This means that subjects not yet displaying any symptoms of coronary heart disease (CHD) predominantly have advanced atherosclerosis of the carotid artery. The positive predictive value (PPV) for hospitalized patients is of course not transferable due to the much lower prevalence of atherosclerosis of the carotid artery in healthy subjects; however, the sensitivity of the carotid duplex in predicting CHD is not dependent upon its prevalence. Subsequently, 408 healthy subjects (73 of them women) with a type III or type IV b finding were contacted and specifically asked if they had experienced, or were experiencing symptoms such as exertional dyspnea or AP. Thirty-six subjects (30 men and six women aged between 43 and 61 years) complained of exertional dyspnea or of atypical AP or typical AP. Four subjects (three men and one woman) had no symptoms at all; however, these subjects elected to undergo further cardiac examinations. In all subjects, there was advanced atherosclerosis of the carotid artery (type III or type IV b finding, Figs. 1 and 2). In 36 subjects, further cardiac assessment was recommended. A comparison was drawn between the results of the ultrasound examination and the exercise electrocardiography (ECG).
Figure 1

Type III in the carotid duplex with TPA under the age-related cut-off.

Figure 2

Type IV b in the carotid duplex with TPA above the age-related cut-off.

Type III in the carotid duplex with TPA under the age-related cut-off. Type IV b in the carotid duplex with TPA above the age-related cut-off.

Methods

The carotid artery (common carotid artery both externally and internally using B-mode ultrasound) was examined on both sides, as far as could be made visible, for plaques on the long and short axis from the clavicle through to the temporomandibular joint in a caudal to cranial direction by means of anterior, anterolateral, lateral and posterolateral insonation. A portable ultrasound device with a 10 MHz linear transducer of the type Imagic Agile and manufactured by the company Kontron Medical was used during testing. Only carotid artery wall thickness increases with an intima media thickness (IMT) > 1 mm were evaluated as plaque. Using the device’s surface area measurement program, it was possible to identify all the plaques in a longitudinal section (the sum total of all plaque surface areas TPA) by tracing the perimeter of each plaque with the cursor at its maximum enlargement in the B-mode image. Furthermore, the maximum plaque thickness was measured. The findings of the ultrasound examinations were classified according to four types ranging from type I to type VI b [1]: type I: no or only minimal atherosclerosis of the carotid artery with a TPA of up to 24 mm2; type II a: only flat plaques ≤ 2 mm IMT with plaque surface area under age-related cut-off in the carotid artery; type II b: only flat plaques ≤ 2 mm IMT with a large plaque surface area above age-related cut-off in the carotid artery; type III: carotid plaques with an IMT ≥ 3.5 mm and a plaque surface area under age-related cut-off; and type IV a: mixed type (with flat carotid plaques and plaques > 2 mm IMT and a plaque surface area under age-related cut-off; type IV b with flat carotid plaques and plaques > 2 mm IMT and a large plaque surface area over age-related cut-off). The TPA cut-off in the subjects < 40 years of age was 60 mm2, from 40 to 49 years of age, it was 80 mm2, from 50 to 59 years of age, it was 110 mm2, and from 60 to 65 years of age, it was 130 mm2. The cut-off for maximum plaque thickness was > 2 mm, or irrespective of the TPA, it was ≥ 3.5 mm. According to this classification, it was possible to predict coronary stenosis in patients who were examined 1 day prior to their undergoing a coronary angiogram with a sensitivity level of 87% [1]. The cardiac assessment was conducted using exercise ECGs, CT coronary angiograms and coronary angiograms. The risk of heart attack was determined using the PROCAM score (www.assmann-stiftung.de).

Results

The initial cardiac diagnostic testing was conducted on 31 patients using an exercise ECG, four patients were assessed using a coronary angiogram, and five further patients were assessed using a CT coronary angiogram. An ultrasound examination of the carotid artery of 39 patients revealed a type IV b finding, and in one patient, the examination revealed a type III finding. The PROCAM score of 17 patients was < 10%, 13 patients had a score between 10% and 20%, and 10 patients had a score > 20%. In the final analysis, two patients had entirely smooth coronary arteries, seven had coronary sclerosis, seven had a 30% stenosis, one patient had a 30-40% stenosis, one patient had a 40% stenosis, five patients had a 50% stenosis, two patients had a 60% stenosis, two patients had a 60-70% stenosis, two patients had a 70% stenosis (a stent was inserted into one of these patients), four patients had an 80% stenosis (a stent was inserted into two of these patients), one patient had a 90% stenosis, two patients had a 95% stenosis (stents were inserted into both these patients), two patients had a vascular occlusion (stents were inserted into both these patients), and two patients underwent emergency bypass surgery following a coronary angiogram (both patients had main stem stenosis, three-vessel disease). The exercise ECG only achieved a true positive result in four patients, and in 21 patients, the result was false negative. In the analysis, the patients with coronary sclerosis are not classified as sick. Among the 10 patients with a high PROCAM score, four had coronary sclerosis and six had a stenosis. Table 1 gives an overview of the clinical data. A type III or type VI b finding is present in 7.28% of the 5,601 subjects who were examined.
Table 1

Test Results of the 40 Patients With a Type III or IV b Finding in the Ultrasound Examination

PROCAMTPAPlaque thicknessType ultrasoundSymptomsRFPTPDiagnosticsCoronary resultTherapyExercise ECG
2.23%1924.6IV bDyspneaLDLExercise ECG, coroSmooth vesselsNoneNegative
4.60%1302.4IV bAtypical APNik, FA14%Exercise ECG, coroSmooth vesselsNoneNegative
35.32%1612.4IV bAtypical APDM, HDL49%Exercise ECG, CTSclerosisConservativeNegative
35.97%1863.2IV bTypical APNik, LDL84%Exercise ECG, CTSclerosisConservativeNegative
39.91%1362.1IV bAtypical APNik, HDL,LDL, FA38%CT, coroSclerosisConservative
11.10%2835.2IV bDyspneaNikExercise ECG, coroSclerosisConservativeNegative
2.73%1794.1IV bTypical APKeine84%CoroSclerosisConservative
27.31%1664.7IV bDyspneaNik, LD, HDL, FACTSclerosisConservative
8.92%1343.1IV bTypical APKeine84%Exercise ECG, CTSclerosisConservativeNegative
11.06%1313.4IV bAtypical APLDL,FAExercise ECG, CT30% stenosisConservativeNegative
32.82%1923.1IV bAtypical APNik, FA49%CT30% stenosisConservative
9.32%1312.2IV bDyspneaNikCT30% stenosisConservative
16.26%1333.3IV bDyspneaNik, HDL, FAExercise ECG, CT, coro30% stenosisConservativeNegative
4.00%1283.5IV bNoneFAExercise ECG, CT30% stenosisConservativeNegative
44.18%1202.3IV bTypical APNik, HDL, DM77%Coro30% stenosisConservative
3.65%1163.2IV bDyspneaNik, FACT30% stenosisConservative
8.17%2604.3IV bTypical APHDL,FA77%Exercise ECG, coro30-40% stenosisConservativeNegative
31.00%1193.7IV bDyspneaLDL,FAExercise ECG, CT, coro40% stenosisConservativeNegative
4.22%1963.6IV bDyspneaKeineExercise ECG, CT50% stenosisConservativeNegative
36.90%1852.4IV bNoneLDL, DM, FAExercise ECG, CT50% stenosisConservativeNegative
21.38%1803.0IV bDyspneaLDL, HDLExercise ECG, CT,coro50% stenosisConservativeNegative
8.32%1274.2IV bDyspneaLDLExercise ECG, coro50% stenosisConservativeNegative
9.38%1302.3IV bTypical APNik. HDL, FA69%Exercise ECG, coro50% stenosisConservativeNegative
5.35%1923.5IV bTypical APKeine84%Coro60% stenosisConservative
13.80%2303.6IV bDyspneaNik, LDL, FAExercise ECG, coro60% stenosisConservativeNegative
6.40%2384.4IV bTypical APNik, DM58%Exercise ECG, coro60-70% stenosisConservativeNegative
15.82%1222.3IV bSynkopenLDL, HDL, NikExercise ECG, CT, coro60-70% stenosisConservativeNegative
5.88%913.8IIINoneFAExercise ECG, CT, coro70% stenosisConservativeNegative
3.95%1312.2IV bNoneKeineExercise ECG, CT, MRT, coro70% stenosisStentingPathological
21.56%2112.5IV bAtypical APHDL, DM49%Exercise ECG, CT, coro80% stenosisStentingNegative
18.93%1302.3IV bAtypical APLDL, FA49%Exercise ECG, CT, coro80% stenosisConservativeNegative
6.28%1362.5IV bTypical APNik, LDL47%Exercise ECG, coro80% stenosisStentingNegative
12.05%2443.5IV bAtypical APDM, FA28%Exercise ECG, coro80% stenosisconservativePathological
18.07%1843.2IV bTypical APNik, FA77%Exercise ECG, coro90% stenosisConservativeNegative
10.60%1042.3IV bTypical APFA, Nik69%Exercise ECG, coro95% stenosisStentingNegative
12.13%1662.8IV bTypical APLDL, FA77%Exercise ECG, coro98% stenosisStentingNegative
11.62%1142.3IV bTypical APLDL77%Exercise ECG, coro100% stenosisStentingPathological
11.29%3204.3IV bDyspneaHDLExercise ECG, coro100% stenosisStentingNegative
5.76%2823.4IV bTypical APKeine84%CoroHS-stenosisBypass
10.14%1452.8IV bTypical APLDL, HDL77%Exercise ECG, coroHS-stenosisBypassPathological

TPA: total plaque area; FA: family history positive; DM: diabetes mellitus; HDL: HDL-cholesterol ≤ 40 mg/dL; LDL: LDL-cholesterol ≥ 180 mg/dL; AP: angina pectoris; coro: coronary angiogram; CT: computed tomography; HS: main stem; RF: risk factor; Nik: nicotine use; KHK: coronary heart disease; PTP: pretest probability; GE: vascular disease; ACS: acute coronary syndrome.

TPA: total plaque area; FA: family history positive; DM: diabetes mellitus; HDL: HDL-cholesterol ≤ 40 mg/dL; LDL: LDL-cholesterol ≥ 180 mg/dL; AP: angina pectoris; coro: coronary angiogram; CT: computed tomography; HS: main stem; RF: risk factor; Nik: nicotine use; KHK: coronary heart disease; PTP: pretest probability; GE: vascular disease; ACS: acute coronary syndrome.

Discussion

Atherosclerosis is an inflammatory disease of the arteries and continues to be the most common cause of death (over 40%) in the developed industrial nations. The disease can even begin from the age of 20 and often remains undetected until it is in its later stages, resulting in clinical events such as acute coronary syndrome (ACS), stable angina, apoplexy and peripheral artery disease (PAD). Several studies demonstrate that even insignificant coronary stenoses are associated with an increased risk of heart attack [2-4]. An extensive multicenter research study (CONFIRM study) using 27,000 CT coronary angiograms revealed that a statin therapy contributes towards an improvement in survival chances even in the case of stenoses < 50% [5]. The improvement in survival chances achieved by using statin therapy in the group of subjects with non-obstructive coronary heart disease was at a hazard ratio of 0.39, 95% confidence interval of 0.23 - 0.65 and a P value of < 0.001. This effect was not verifiable in the group with normal coronary arteries. It therefore appears important that atherosclerosis is both diagnosed and treated in its early stages in order to delay the final outcome of the disease as long into the future as is possible. In the case of out-patient diagnostics, the exercise ECG still plays an important role in the diagnosis of suspected CHD. The sensitivity of the exercise ECG in diagnosing coronary stenosis is only 45-50%. The importance of the exercise ECG in diagnosing coronary stenosis was therefore downgraded in the most recent guidelines [6]. In the case of a pretest probability (PTP) of between 15% and 65%, an exercise ECG is initially recommended. The exercise ECG only achieved a true positive result in four patients, and in 21 patients, the result was false negative; therefore no treatment was initiated with these patients. In view of the low number of subjects, it is not possible to evaluate these statistics using the PPV); however, the results indicate that the ultrasound examination is significantly more effective in the diagnosis of suspected CHD. It would be therefore desirable if a widely available, inexpensive, non-invasive diagnostic tool with a high level of accuracy and free from side effects was developed. The results of the study indicate that this could be achieved with the combination of TPA measurement and determining the maximum plaque thickness of the carotid artery. An evaluation of 500 ultrasound examinations carried out on patients 1 day prior to their undergoing a coronary angiogram revealed an 87% level of sensitivity in predicting a coronary stenosis of at least 50% following a type III or IV b ultrasound finding [1]. A further study which was conducted revealed similar results [7]. The follow-up study to date has demonstrated that subjects with advanced atherosclerosis (type III or type IV b findings) are at significantly increased risk of having cardiovascular disease. In the case of 40 patients (heart attack, stroke, bypass surgery, stent implantation, and existing stenosing coronary heart condition), 30 had a type III or a type IV b finding during the carotid duplex in the baseline study. From a further 40 subjects (36 with symptoms and four asymptomatic) with advanced atherosclerosis of the carotid artery who underwent cardiac diagnostic testing, 22 were found to have a stenosing coronary heart condition, nine had a stenosis of up to 40%, and seven had coronary sclerosis. Only two patients had entirely smooth coronary arteries. Cardiac assessment using an exercise ECG is insufficient. In order to confidently rule out CHD, it is necessary to conduct a coronary CT even if tests for ischemia are negative. Determining the PROCAM score is meaningful since the notorious risk factors (RFs) are taken into consideration; however, the PROCAM score does not accurately display the risks associated with atherosclerosis of the carotid artery. Out of a total of 5,601 examined subjects, 7.28% had a type III or type IV b finding in the ultrasound examination. Forty-seven percent of the men examined with a type III or type IV b finding had a low PROCAM score, and in the cases of women, even 85% with a type III or type IV b finding had a low PROCAM score. From the 71 patients in total, 38.1% had a low PROCAM score and 36.6% had a score indicating intermediate risk. This demonstrates that the PROCAM score is of little preventative value in individual cases. Using ultrasound screening of the carotid artery on subjects with a high level of cardiovascular risk means that they can be both easily and inexpensively diagnosed and thus treated early. It is very probable that a number of asymptomatic subjects with advanced atherosclerosis (particularly those subjects who also have several other RFs for cardiovascular disease) already have an existing asymptomatic coronary heart condition which would respond favorably to treatment with statins. Further research is therefore required in this area in order to promote better preventative medicine.

Conclusions

Subjects with symptoms such as exertional dyspnea, atypical or typical AP, and advanced atherosclerosis of the carotid artery (type III or type IV b finding) have a high risk of CHD. Cardiac assessment using an exercise ECG is insufficient since the sensitivity level of this test is too low. An early diagnosis of CHD using ischemia imaging proves unsuccessful since no ischemia is present. The PROCAM score also does not close this diagnostic gap since it does not accurately display the risks associated with atherosclerosis. Further clarification is required as to whether (also in the case of asymptomatic subjects with advanced atherosclerosis and several other RFs) a coronary heart condition is already present that would respond favorably to treatment with statins.

Limitations

Only a small number of patients were examined.
  7 in total

1.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Authors:  Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

3.  [Prediction of coronary artery stenosis by measurement of total plaque area and thickness versus intima media thickness of the carotid artery].

Authors:  Ansgar Adams; Waldemar Bojara
Journal:  Herz       Date:  2015-05-22       Impact factor: 1.443

4.  Carotid Ultrasound Maximum Plaque Height-A Sensitive Imaging Biomarker for the Assessment of Significant Coronary Artery Disease.

Authors:  Amer M Johri; Pearl Behl; Marie-France Hétu; Mohammad Haqqi; Paul Ewart; Andrew G Day; Brendan Parfrey; Murray F Matangi
Journal:  Echocardiography       Date:  2015-06-29       Impact factor: 1.724

5.  A prospective natural-history study of coronary atherosclerosis.

Authors:  Gregg W Stone; Akiko Maehara; Alexandra J Lansky; Bernard de Bruyne; Ecaterina Cristea; Gary S Mintz; Roxana Mehran; John McPherson; Naim Farhat; Steven P Marso; Helen Parise; Barry Templin; Roseann White; Zhen Zhang; Patrick W Serruys
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

6.  Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry.

Authors:  Benjamin J W Chow; Gary Small; Yeung Yam; Li Chen; Ruth McPherson; Stephan Achenbach; Mouaz Al-Mallah; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Y Cheng; Kavitha Chinnaiyan; Ricardo Cury; Augustin Delago; Allison Dunning; Gundrun Feuchtner; Martin Hadamitzky; Jörg Hausleiter; Ronald P Karlsberg; Philipp A Kaufmann; Yong-Jin Kim; Jonathon Leipsic; Troy LaBounty; Fay Lin; Erica Maffei; Gilbert L Raff; Leslee J Shaw; Todd C Villines; James K Min
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-12       Impact factor: 8.311

7.  Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms: 10-year follow-up of 521 patients.

Authors:  W L Proudfit; V G Bruschke; F M Sones
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

  7 in total
  7 in total

1.  Identifying potential signatures for atherosclerosis in the context of predictive, preventive, and personalized medicine using integrative bioinformatics approaches and machine-learning strategies.

Authors:  Jinling Xu; Hui Zhou; Yangyang Cheng; Guangda Xiang
Journal:  EPMA J       Date:  2022-07-20       Impact factor: 8.836

2.  Identification of Biomarkers of Autophagy-Related Genes Between Early and Advanced Carotid Atherosclerosis.

Authors:  Yuanyuan Zhang; He Zhang
Journal:  Int J Gen Med       Date:  2022-05-31

3.  Impact of Circulating Triglycerides Concentration on Atherosclerotic Disease Status in Middle-Aged Saudi Arabian Dwellers.

Authors:  Wedad Azhar; Bartek Buczkowski; Christopher Smith; Gladys Onambele-Pearson
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

4.  Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.

Authors:  Mikyung Yu; Carleena A Ortega; Kevin Si; Roberto Molinaro; Frederick J Schoen; Renata F C Leitao; Xiaoding Xu; Morteza Mahmoudi; Suyeon Ahn; Jerry Liu; Phei Er Saw; In-Hyun Lee; Mirna M B Brayner; Azita Lotfi; Jinjun Shi; Peter Libby; Sangyong Jon; Omid C Farokhzad
Journal:  Theranostics       Date:  2018-11-15       Impact factor: 11.556

5.  The association of coronary non-calcified plaque loading based on coronary computed tomography angiogram and adverse cardiovascular events in patients with unstable coronary heart disease-a retrospective cohort study.

Authors:  Tianhong Yi; Suqun Huang; Daimin Li; Yao She; Ke Tan; Yi Wang
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

6.  Early Diagnosis and Treatment of Coronary Heart Disease in Asymptomatic Subjects With Advanced Vascular Atherosclerosis of the Carotid Artery (Type III and IV b Findings Using Ultrasound) and Risk Factors.

Authors:  Ansgar Adams; Waldemar Bojara; Klaus Schunk
Journal:  Cardiol Res       Date:  2018-02-11

Review 7.  A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.

Authors:  Albino Carrizzo; Carmine Izzo; Maurizio Forte; Eduardo Sommella; Paola Di Pietro; Eleonora Venturini; Michele Ciccarelli; Gennaro Galasso; Speranza Rubattu; Petro Campiglia; Sebastiano Sciarretta; Giacomo Frati; Carmine Vecchione
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.